House subpanel approves a boost for device center
This article was originally published in The Gray Sheet
Executive Summary
A House Appropriations subcommittee approved on June 30 a $7 million increase over the $325.7 million that the Obama administration had requested for CDRH's fiscal year 2011 budget ("1The Gray Sheet" Feb. 8, 2010). The subcommittee version of the bill would provide FDA with a total of $3.77 billion for the fiscal year beginning Oct. 1, including $2.57 billion in federal funds and $1.2 billion from various industry user fees. The funds include a $65 million package aimed at bolstering staff reviews of generic drug applications and drug company ads, as well as "more funds to safeguard clinical trials," Subcommittee Chair Rosa DeLauro, D-Conn., said. The bill now goes to the House Appropriations Committee for refinements and approval. The Senate Appropriations subcommittee with jurisdiction has yet to propose funding levels for FDA